We demonstrate the successful application of exome sequencing1,2,3 to discover a gene for an autosomal dominant disorder, Kabuki syndrome (OMIM%147920). We subjected the exomes of ten unrelated probands to massively parallel sequencing. After filtering against existing SNP databases, there was no compelling candidate gene containing previously unknown variants in all affected individuals. Less stringent filtering criteria allowed for the presence of modest genetic heterogeneity or missing data but also identified multiple candidate genes. However, genotypic and phenotypic stratification highlighted MLL2, which encodes a Trithorax-group histone methyltransferase4: seven probands had newly identified nonsense or frameshift mutations in this gene. Follow-up Sanger sequencing detected MLL2 mutations in two of the three remaining individuals with Kabuki syndrome (cases) and in 26 of 43 additional cases. In families where parental DNA was available, the mutation was confirmed to be de novo (n = 12) or transmitted (n = 2) in concordance with phenotype. Our results strongly suggest that mutations in MLL2 are a major cause of Kabuki syndrome.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Choi, M. et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl. Acad. Sci. USA 106, 19096–19101 (2009).
Ng, S.B. et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat. Genet. 42, 30–35 (2010).
Ng, S.B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272–276 (2009).
FitzGerald, K.T. & Diaz, M.O. MLL2: A new mammalian member of the trx/MLL family of genes. Genomics 59, 187–192 (1999).
Niikawa, N., Matsuura, N., Fukushima, Y., Ohsawa, T. & Kajii, T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J. Pediatr. 99, 565–569 (1981).
Kuroki, Y., Suzuki, Y., Chyo, H., Hata, A. & Matsui, I. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J. Pediatr. 99, 570–573 (1981).
Niikawa, N. et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am. J. Med. Genet. 31, 565–589 (1988).
Courtens, W., Rassart, A., Stene, J.J. & Vamos, E. Further evidence for autosomal dominant inheritance and ectodermal abnormalities in Kabuki syndrome. Am. J. Med. Genet. 93, 244–249 (2000).
Cooper, G.M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15, 901–913 (2005).
Cooper, G.M. et al. Single-nucleotide evolutionary constraint scores highlight disease-causing mutations. Nat. Methods 7, 250–251 (2010).
Prasad, R. et al. Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax. Oncogene 15, 549–560 (1997).
Issaeva, I. et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol. Cell. Biol. 27, 1889–1903 (2007).
Glaser, S. et al. Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. Development 133, 1423–1432 (2006).
Tonoki, H., Saitoh, S. & Kobayashi, K. Patient with del(12)(q12q13.12) manifesting abnormalities compatible with Noonan syndrome. Am. J. Med. Genet. 75, 416–418 (1998).
We thank the families for their participation and the Kabuki Syndrome Network for their support. We thank J. Allanson, J. Carey and M. Golabi for referral of cases and M. Emond for helpful discussion. We thank the 1000 Genomes Project for early data release that proved useful for filtering out common variants. Our work was supported in part by grants from the US National Institutes of Health (NIH)–National Heart, Lung, and Blood Institute (5R01HL094976 to D.A.N. and J.S.), the NIH–National Human Genome Research Institute (5R21HG004749 to J.S., 1RC2HG005608 to M.J.B., D.A.N. and J.S.; and 5RO1HG004316 to H.K.T.), NIH–National Institute of Environmental Health Sciences (HHSN273200800010C to D.N. and M.J.R.), Ministry of Health, Labour and Welfare (K.Y., N.M., T.O. and N.N.), Japan Science and Technology Agency (N.M.), Society for the Promotion of Science (N.M.), the Life Sciences Discovery Fund (2065508 and 0905001), the Washington Research Foundation and the NIH–National Institute of Child Health and Human Development (1R01HD048895 to M.J.B.). S.B.N. is supported by the Agency for Science, Technology and Research, Singapore. A.W.B. is supported by a training fellowship from the NIH–National Human Genome Research Institute (T32HG00035).
The authors declare no competing financial interests.
About this article
Cite this article
Ng, S., Bigham, A., Buckingham, K. et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42, 790–793 (2010). https://doi.org/10.1038/ng.646
The circadian machinery links metabolic disorders and depression: A review of pathways, proteins and potential pharmacological interventions
Life Sciences (2021)
Neonatal hyperinsulinemic hypoglycemia: case report of kabuki syndrome due to a novel KMT2D splicing-site mutation
Italian Journal of Pediatrics (2020)
Current Allergy and Asthma Reports (2020)
Customised next-generation sequencing multigene panel to screen a large cohort of individuals with chromatin-related disorder
Journal of Medical Genetics (2020)
Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders